IN VITRO IMMUNE-MODULATORY POTENTIAL OF CRUDE EXTRACT OF LEAFS OF ALBIZIA GUMMIFERA AGAINST STIMULATED PERIPHERAL BLOOD MONONUCLEAR AND RAW CELLS
DOI:
https://doi.org/10.21010/ajtcam.v12i3.10Keywords:
Albizia gummifera, Interleukin-2, nitric oxideAbstract
The effect of crude leaf extract of Albizia gummifera (5-160µg/ml) was evaluated on cytotoxic activity against peripheral blood mononuclear and RAW cells stimulated with phorbol myristate acetate (25ng/ml) and formyl peptides (1µM) respectively using the WST-1 technique. Nitric oxide production by RAW cells and Intereukin-2 (IL-2) production by PBMC were also assessed at the same crude leaf extract concentrations (5-160µg/ml) employing colorimetric procedures. The plant leaf extract dose-dependently inhibited growth of mononuclear cells while promoting that of RAW cells (p<0.05). Interleikin-2 production by mononuclear cells and nitric oxide release by RAW cells were inhibited and promoted respectively (p<0.05). Phytochemical studies showed that the leaf extract tested positive for flavonoids, saponins and tannins. This is a preliminary study that showed significant anti- and pro-inflammatory potential at concentration above 20 and 40µg/ml respectively. Further laboratory research is essential to elucidate the anti- and pro-inflammatory biochemical pathways as shown by the in vitro immune-modulatory modalities of this plant species. It is also important to further identify bioactive entities of Albizia gummifera responsible for the observed activities.Downloads
Published
How to Cite
Issue
Section
License
Copyright: Creative Commons Attribution CC.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.